Search results
Q1 2024 scPharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoWe are encouraged by the prescriber growth in this quarter as we believe it reflects our strategy of establishing a broader prescriber base. Importantly, more than half of these prescribers ...
DeMarco wastes no time, wants pledges from congressional nominees on prescription drug costs
Maryland Matters via Yahoo News· 2 days agoCandidates who sign the pledge promise to 'oppose any efforts to weaken the prescription drug affordability provisions in the Inflation Reduction Act.' The post DeMarco wastes ...
Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call Transcr
Guru Focus· 3 days agoThe company successfully launched ZORYVE foam for seborrheic dermatitis, achieving over 46,000 prescriptions in less than three months. Arcutis Biotherapeutics Inc (ARQT) ...
Short-Term Market Volatility Could Provide Long-Term Investing Opportunities
Morningstar· 7 days agoWhy Morningstar thinks Apple could turn it around for 2025. Plus, the Federal Reserve is delaying...
Today’s political parties seem dumb and dumber; candidate endorsements for Tuesday’s election |...
CapitalGazette.com· 5 days agoHow different are the Democrat and Republican parties? People on the political extremes look at Democrats and Republicans and don’t see a dime’s worth of difference between them. It’s also long ...
Washington Healthcare Update - May 2024 #2 | JD Supra
JD Supra· 3 days agoThis Week in Washington: House Ways and Means Committee marks up telehealth legislation; CMS extends state Medicaid unwinding flexibilities; Senate...
JD Supra: The Focus of Federal Proposals on Pharmacy Benefit Management – 118th Congress
JD Supra· 1 day agoOver the past several years, legislators across the country have focused their attention on Pharmacy Benefit Managers (PBMs) due to concerns expressed over a variety of industry...
Recent Developments in Pharmacy-Related Legislation and Regulations | JD Supra
JD Supra· 2 days agoOver the last two months, there has been a steady influx of regulatory and legislative efforts regarding drug pricing and the pharmacy industry. In April, the U.S. Government Accountability ...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows By Reuters
Investing.com· 6 days agoThe data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
Reuters via Yahoo News· 6 days agoThe data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as...